Align Technology | ALGN - Cash And Equivalent

Stock Price
175.62
Daily Change
14.32 8.88%
Monthly
4.75%
Yearly
-19.58%
Q1 Forecast
158.01

Align Technology reported $1B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
3M USD 5.24B 564M Dec/2025
Align Technology USD 1B 103.43M Sep/2025
Becton, Dickinson and Co. USD 641M 94M Sep/2025
Bruker USD 293.1M 201.1M Sep/2025
Cardinal Health USD 2.78B 1.82B Dec/2025
Charles River Laboratories USD 207.1M 24.27M Sep/2025
Cooper Companies USD 124.9M 13.3M Jun/2025
CVS Health USD 9.1B 2.69B Sep/2025
Danaher USD 4.62B 3.09B Dec/2025
Dentsply International USD 363M 4M Sep/2025
Dexcom USD 1.84B 676.7M Sep/2025
Henry Schein USD 136M 9M Sep/2025
Idexx Laboratories USD 208.17M 43.57M Sep/2025
Insulet USD 757.4M 364.2M Sep/2025
Integra LifeSciences USD 232.19M 14.27M Sep/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
Masimo USD 312.3M 162.7M Sep/2025
McKesson USD 2.96B 1.05B Dec/2025
Mettler Toledo International USD 69.06M 7.24M Sep/2025
Revvity USD 931.39M 60.46M Sep/2025
Solventum Corp USD 1.64B 1.15B Sep/2025
Stryker USD 3.26B 881M Sep/2025
Teleflex USD 354M 100.3M Sep/2025
Thermo Fisher Scientific USD 9.85B 7.87B Dec/2025
Veeva Systems USD 1.66B 270.29M Sep/2025
Waters USD 459.12M 91.9M Sep/2025
Zimmer Biomet Holdings USD 1.29B 735.8M Sep/2025
Zoetis USD 2.08B 649M Sep/2025